Luven Diagnostic (LVN)
|Whitelist of investors:||No|
|KYC of investors:||No|
|Goal of funding:||30 000 000 USD|
|Tokens for sale:||30 000 000 LVN|
|Token price:||1 LVN = 0.003448 ETH|
|Have escrow agent:||No|
|Have working prototype:||Yes|
Unique cancer diagnostic technology designed to save millions of lives. The Luven technology allows to detect the disease in its early stages, thus, preventing its progression in thousands of patients.
|●||1st week of ICO:||10%|
|●||>= 5,000 ETH:||5%|
|●||>= 3,000 ETH:||4%|
|●||>= 1,000 ETH:||3%|
|●||>= 100 ETH:||2%|
|●||>= 3 ETH:||1%|
01.01.2004 A cytomorphobiologial diagnostic method appeared
01.01.2010 The software a part of the diagnostic was created
01.01.2014 The diagnostic method was patented
01.01.2015 launching a franchise
01.01.2016 Software enhancement, additional clinical trials.
01.09.2017 Preparing and starting a preICO
15.01.2018 Starting an ICO
01.04.2018 contracts with clinics worldwide for clinical trials
01.01.2019 Opening 20 new labs in the European Union
01.01.1983 Development of the cancer diagnostic method
CEO, Team Leadership
CTO, Developer, Lead Software engineer
Geneticist & Cytologist
Principal Software Engineer
We are a group of enthusiasts who believe, that every person can make a difference by supporting the...
As a response to rapidly emerging eye health problem EyeGlob.Net will provide a mix of social and pr... Full info
Doctor Smart is an ecosystem for digital health based on unique technology. The platform uses utilit...
An $872 billion dollar industry on the Blockchain, enabling access to affordable healthcare globally...
ZENITH introduces the opening of the world’s first blockchain organization to help world health, Sm...
A new revolution in the medical industry begins with MEDK project. Based on blockchain technology, M...
Functional water with unique health benefits
The TeamMate Network aims to integrate the health, fitness and wellness industries into a unified bl...
Helix3 is a platform that offers a secure way for the healthcare industry to drive patient value, en...